Misdiagnosis of clear cell renal cell carcinoma

Nature Reviews Urology

Volumn 8, Issue 6, 2011, Pages 321-333

  Valera, Vladimir A ^a   Merino, Maria J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PATIENT; CLEAR CELL CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; MORPHOLOGY; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SYMPTOM; TUMOR CELL;

ANIMALS; CARCINOMA, RENAL CELL; DIAGNOSTIC ERRORS; HUMANS; KIDNEY NEOPLASMS;

EID: 79958840728     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.64     Document Type: Review

References (83)

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer Statistics, 2010. CA Cancer J. Clin. 60, 277-300 (2010).
2. Ferlay, J. et al. GLOBOCAN 2008: Cancer incidence and mortality worldwide. International Agency for Research on Cancer [online], http://globocan.iarc.fr (2010).
3. Kümmerlin, I. P. E. D., Laguna, M. P., de la Rosette, J. J. M. C. H. & Bossuyt, P. M. M. in Renal Cell Cancer (eds de la Rosette, J. J. M. C. H., Sternberg, C. N. & van Poppel, H. P. A.) 1-8 (Springer, London, 2008).
4. Hunt, J. D., van der Hel, O. L., McMillan, G. P., Boffetta, P. & Brennan, P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int. J. Cancer 114, 101-108 (2005).
5. Chow, W. H., Dong, L. M. & Devesa, S. S. Epidemiology and risk factors for kidney cancer. Nat. Rev. Urol. 7, 245-257 (2010).
6. Dhote, R., Thiounn, N., Debré, B. & Vidal-Trecan, G. Risk factors for adult renal cell carcinoma. Urol. Clin. North Am. 31, 237-247 (2004).
7. Pascual, D. & Borque, A. Epidemiology of kidney cancer. Adv. Urol. 782381 (2008).
8. Linehan, W. M. et al. Hereditary kidney cancer: unique opportunity for disease-based therapy. Cancer 115, 2252-2261 (2009).
9. Schmidt, L. S. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma. Curr. Mol. Med. 4, 877-885 (2004).
10. Refae, M. A., Wong, N., Patenaude, F., Bégin, L. R. & Foulkes, W. D. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat. Clin. Pract. Oncol. 4, 256-261 (2007).
11. Schreiner, A. et al. Distinctive morphology of renal cell carcinomas in tuberous sclerosis. Int. J. Surg. Pathol. 18, 409-418 (2009).
12. Ricketts, C. et al. Germline SDHB mutations and familial renal cell carcinoma. J. Natl Cancer Inst. 100, 1260-1262 (2008).
13. Nishimura, H. et al. Renal cell carcinoma in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 54, 165-168 (2009).
14. Hajj, P. et al. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74, 631-634 (2009).
15. Sunela, K. L., Kataja, M. J. & Kellokumpu-Lehtinen, P. L. Changes in symptoms of renal cell carcinoma over four decades. BJU Int. 106, 649-653 (2010).
16. Jacques, A. E. T. & Reznek, R. H. in Imaging in Oncological Urology (eds de la Rosettem J. J. M. C. H., Manyak, M. J., Haringhani, M. G. & Wijkstra) 61-83 (Springer, London, 2009).
17. Pantuck, A. J., Zisman, A., Rauch, M. K. & Belldegrun, A. Incidental renal tumors. Urology 56, 190-196 (2000).
18. Motzer, R. J., Russo, P., Nanus, D. M. & Berg, W. J. Renal cell carcinoma. Curr. Probl. Cancer 21, 185-232 (1997).
19. Nguyen, M. M., Gill, I. S. & Ellison, L. M. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J. Urol. 176, 2397-2400 (2006).
20. Chawla, S. N. et al. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J. Urol. 175, 425-431 (2006).
21. Martignoni, G. et al. in Clinical Pathology of Urologic Tumors (ed. Mikuz, G.) 253 (Informa Healthcare, Boca Raton, FL, 2007).
22. Decastro, G. J. & McKiernan, J. M. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol. Clin. North Am. 35, 581-592 (2008).
23. Gold, P. J., Fefer, A. & Thompson, J. A. Paraneoplastic manifestations of renal cell carcinoma. Semin. Urol. Oncol. 14, 216-222 (1996).
24. Sheth, S. & Fishman, E. In Imaging of Kidney Cancer (eds Guermazi, A. & Abo-Kamil, R.) 29-47 (Springer, Berlin, Heidelberg, New York, 2006).
25. Tello, R. et al. MR imaging of renal masses interpreted on CT to be suspicious. AJR Am. J. Roentgenol. 174, 1017-1022 (2000).
26. Valera, V. A. et al. Protein expression profiling in the spectrum of renal cell carcinomas. J. Cancer 1, 184-196 (2010).
27. International Agency for Research on Cancer. Pathology and genetics of tumours of the urinary system and male genital organs. International Agency for Research on Cancer [online], http://www.iarc.fr/en/publications/pdfs-online/pat- gen/bb7/bb7-cover.pdf (2004).
28. Grignon, D. J. & Che, M. Clear cell renal cell carcinoma. Clin. Lab. Med. 25, 305-316 (2005).
29. Lohse, C. M. & Cheville, J. C. A review of prognostic pathologic features and algorithms for patients treated surgically for renal cell carcinoma. Clin. Lab. Med. 25, 433-464 (2005).
30. Jinzaki, M. et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J. Comput. Assist. Tomogr. 24, 835-842 (2000).
31. Herts, B. R. et al. Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys. AJR Am. J. Roentgenol. 178, 367-372 (2002).
32. Pedrosa, I. et al. MR classification of renal masses with pathologic correlation. Eur. Radiol. 18, 365-375 (2008).
33. Outwater, E. K., Bhatia, M., Siegelman, E. S., Burke, M. A. & Mitchell, D. G. Lipid in renal clear cell carcinoma: detection on opposed-phase gradient-echo MR images. Radiology 205, 103-107 (1997).
34. Yoshimitsu, K. et al. MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient-echo imaging. J. Magn. Reson. Imaging 9, 579-585 (1999).
35. Raj, G. V. et al. Predicting the histology of renal masses using preoperative Doppler ultrasonography. J. Urol. 177, 53-58 (2007).
36. Murphy, W. M., Grignon, D. J., Perlman, E. J. & American Registry of Pathology. in Tumors of the Kidney, Bladder, and Related Urinary Structures (eds Murphy, W. M., Grignon, D. J., Perlman, E. J. & American Registry of Pathology) 109-121 (American Registry of Pathology, Washington, DC, 2004).
37. Frank, I. et al. Solid renal tumors: an analysis of pathological features related to tumor size. J. Urol. 170, 2217-2220 (2003).
38. Fuhrman, S. A., Lasky, L. C. & Limas, C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 6, 655-663 (1982).
39. Ficarra, V. et al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103, 68-75 (2005).
40. Rioux-Leclercq, N. et al. Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer 109, 868-874 (2007).
41. Reuter, V., Russo, P. & Motzer, R. J. in Comprehensive Textbook of Genitourinary Oncology (eds Vogelzang, N., Scardino, P. & Shipley, W. U.) 680-710 (Lippincott Williams & Wilkins, Philadelphia, 2006).
42. th edn (eds Carter, D., Greenson, J. K., Oberman, H. A., Reuter, V. E. & Stohler, M. H.) 1955 (Lippincott Williams & Wilkins, Philadelphia, 2004).
43. Hammerich, K. H., Ayala, G. E. & Wheeler, T. M. Application of immunohistochemistry to the genitourinary system (prostate, urinary bladder, testis, and kidney). Arch. Pathol. Lab. Med. 132, 432-440 (2008).
44. Mackay, B., Ordonez, N. G., Khoursand, J. & Bennington, J. L. The ultrastructure and immunocytochemistry of renal cell carcinoma. Ultrastruct. Pathol. 11, 483-502 (1987).
45. Erlandson, R. A., Shek, T. W. & Reuter, V. E. Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors. Ultrastruct. Pathol. 21, 409-417 (1997).
46. Linehan, W. M., Rubin, J. S. & Bottaro, D. P. VHL loss of function and its impact on oncogenic signaling networks in clear cell renal cell carcinoma. Int. J. Biochem. Cell Biol. 41, 753-756 (2009).
47. McRonald, F. E. et al. CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma. Mol. Cancer 8, 31 (2009).
48. Cohen, H. T. & McGovern, F. J. Renal-cell carcinoma. N. Engl. J. Med. 353, 2477-2490 (2005).
49. Wiesener, M. S. et al. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1α in clear cell renal carcinomas. Cancer Res. 61, 5215-5222 (2001).
50. Varela, I. et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469, 539-542 (2011).
51. Schuetz, A. N. et al. Molecular classification of renal tumors by gene expression profiling. J. Mol. Diagn. 7, 206-218 (2005).
52. Young, A. N., Master, V. A., Paner, G. P., Wang, M. D. & Amin, M. B. Renal epithelial neoplasms: diagnostic applications of gene expression profiling. Adv. Anat. Pathol. 15, 28-38 (2008).
53. Zhuang, Z. et al. From tissue phenotype to proteotype: sensitive protein identification in microdissected tumor tissue. Int. J. Oncol. 28, 103-110 (2006).
54. Fridman, E. et al. Accurate molecular classification of renal tumors using microRNA expression. J. Mol. Diagn. 12, 687-696 (2010).
55. Hafron, J. et al. Imaging characteristics of minimal fat renal angiomyolipoma with histologic correlations. Urology 66, 1155-1159 (2005).
56. Oliva, M. R. et al. Renal cell carcinoma: T1 and T2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR Am. J. Roentgenol. 192, 1524-1530 (2009).
57. Quaia, E., Bussani, R., Cova, M. & Mucelli, R. P. Radiologic-pathologic correlations of intratumoral tissue components in the most common solid and cystic renal tumors. Pictorial review. Eur. Radiol. 15, 1734-1744 (2005).
58. Shinmoto, H. et al. Small renal cell carcinoma: MRI with pathologic correlation. J. Magn. Reson. Imaging 8, 690-694 (1998).
59. Somani, B. K. et al. Image-guided biopsy-diagnosed renal cell carcinoma: critical appraisal of technique and long-term follow-up. Eur. Urol. 51, 1289-1295 (2007).
60. Samplaski, M. K., Zhou, M., Lane, B. R., Herts, B. & Campbell, S. C. Renal mass sampling: an enlightened perspective. Int. J. Urol. 18, 5-19 (2011).
61. Kummerlin, I. et al. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol. Res. Pract. 205, 27-34 (2009).
62. Truong, L. D. & Shen, S. S. Immunohistochemical diagnosis of renal neoplasms. Arch. Pathol. Lab. Med. 135, 92-109 (2011).
63. Paraf, F. et al. Clear cell carcinoma of the thyroid; diagnostic difficulties [French]. Ann. Pathol. 9, 369-372 (1989).
64. Cameron, R. I., Ashe, P., O'Rourke, D. M., Foster, H. & McCluggage, W. G. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma. Int. J. Gynecol. Pathol. 22, 272-276 (2003).
65. Cajulis, R. S., Katz, R. L., Dekmezian, R., el-Naggar, A. & Ro, J. Y. Fine needle aspiration biopsy of renal cell carcinoma. Cytologic parameters and their concordance with histology and flow cytometric data. Acta Cytol. 37, 367-372 (1993).
66. Renshaw, A. A., Lee, K. R., Madge, R. & Granter, S. R. Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma. Acta Cytol. 41, 987-994 (1997).
67. Eshed, I., Elias, S. & Sidi, A. A. Diagnostic value of CT.guided biopsy of indeterminate renal masses. Clin. Radiol. 59, 262-267 (2004).
68. Richter, F., Kasabian, N. G., Irwin, R. J. Jr, Watson, R. A. & Lang, E. K. Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies. Urology 55, 348-352 (2000).
69. Wood, B. J. et al. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J. Urol. 161, 1470-1474 (1999).
70. Lechevallier, E. et al. Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216, 506-510 (2000).
71. Wang, R., Li, A. Y. & Wood, D. P. Jr. The role of percutaneous renal biopsy in the management of small renal masses. Curr. Urol. Rep. 12, 18-23 (2011).
72. Rybicki, F. J. et al. Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am. J. Roentgenol. 180, 1281-1287 (2003).
73. Silverman, S. G., Gan, Y. U., Mortele, K. J., Tuncali, K. & Cibas, E. S. Renal masses in the adult patient: the role of percutaneous biopsy. Radiology 240, 6-22 (2006).
74. Schmidt, L. S. et al. Birt.Hogg.Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am. J. Hum. Genet. 69, 876-882 (2001).
75. Pavlovich, C. P. et al. Renal tumors in the Birt.Hogg.Dube syndrome. Am. J. Surg. Pathol. 26, 1542-1552 (2002).
76. Kiuru, M. & Launonen, V. Hereditary leiomyomatosis and renal cell cancer (HLRCC). Curr. Mol. Med. 4, 869-875 (2004).
77. Linehan, W. M. et al. Molecular diagnosis and therapy of kidney cancer. Annu. Rev. Med. 61, 329-343 (2010).
78. Lehtonen, H. J. et al. Conventional renal cancer in a patient with fumarate hydratase mutation. Hum. Pathol. 38, 793-796 (2007).
79. Petersen, R. O., Sesterhenn, I. & Davis, C. J. in Urologic Pathology 45-65 (Lippincott Williams & Wilkins, Philadelphia, 2009).
80. Bernstein, J., Robbins, T. O. & Kissane, J. M. The renal lesions of tuberous sclerosis. Semin. Diagn. Pathol. 3, 97-105 (1986).
81. Astuti, D. et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49-54 (2001).
82. Stedman, T. L. Stedman's Medical Dictionary (Lippincott Williams & Wilkins, Philadelphia, 2006).
83. Merriam-Webster Inc. Merriam-Webster dictionary (Merriam-Webster, Springfield, 2005).